A sensitive and selective method for the simultaneous determination of carvedilol and ampicillin sodium (AS) in the presence of human serum albumin (HSA) is described. The maximum emission wavelengths of carvedilol and AS are at 357 nm and 426 nm with excitation at 254 nm, respectively. The first-derivative peaks of carvedilol and AS were at 337 nm and 398 nm, respectively. The linear-regression equations of the calibration graphs of carvedilol and AS were C = 0.0001H -0.0063 and C = 1.530H -43.84; the correlation coefficients were 0.9990 and 0.9986, respectively. The detection limits were 1 ng ml -1 for carvedilol and 23 µg ml -1 for AS, respectively. The effects of the pH, the stability of carvedilol and AS and foreign ions on the determination of carvedilol and AS were examined. The recoveries of carvedilol and AS were measured. This method is simple and can be used for the determination of carvedilol and AS in human serum and urine samples with satisfactory results.
Introduction
Carvedilol, chemically (2RS)-1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol, is one of the medicines that can mitigate tardive movement disorders, psychosis and depression. 1, 2 Ampicilin sodium is one of the important penicillin antibiotics used to treat or prevent bacterial infections. Both drugs are used often to treat heart trouble in the clinic. Furthermore, both drugs are coexistent with protein in vivo, and human serum albumin (HSA) is the most abundant protein in the circulatory system, which often interferes with an assay. Thereby, it is of importance to simultaneously assay carvedilol and ampicillin sodium in the presence of HSA. Methods for the determination of carvedilol by highperformance liquid chromatography and capillary electrophoresis in human serum, plasma, human tissue and rat plasma have been reported; 3-9 they need a precipitation protein, extraction or derivatization sample. The methods used for the determination of ampicillin sodium, such as UVspectrophotometry, [10] [11] [12] [13] derivative-spectrophotometry, [14] [15] [16] highperformance liquid chromatography, [17] [18] [19] flow-injection analysis, 20 thin-layer chromatography, 21 direct titration, 22 cathodic stripping voltammetry, 23 and anion-exchange chromatography 24 were developed. However, the simultaneous determination of carvedilol and ampicillin sodium has not been reported in the presence of HSA. This paper describes a sensitive and selective method for simultaneous determination of carvedilol and ampicillin sodium (AS) in the presence of human serum albumin (HSA). The maximum emission wavelengths of carvedilol and AS were at 357 nm and 426 nm with the excitation at 254 nm, respectively. HSA had a very broad emission range from 300 nm to 450 nm with excitation at 254 nm. Obviously, the emission spectra of carvedilol, ampicillin sodium and HSA were overlapped. The determination of carvedilol and AS by normal fluorometry was difficult in the presence of HSA. Moreover, the synchronous fluorescence method cannot be used to determine the carvedilol or AS in the presence of HSA because of the background of HSA. Fortunately, first-derivative fluorometry can not only eliminate the background interference of HSA, but can also entirely separate the derivative peaks of carvedilol and AS; therefore, carvedilol and AS can be determined directly by firstderivative fluorometry. This method can be used for the simultaneous determination of carvedilol and AS in the samples of urine and human serum with satisfactory results.
Experimental

Apparatus
Spectrofluorometric measurements were made on an LS-50 (Perkin-Elmer, USA) spectrofluorometer equipped with a xenon dischange lamp and 1 cm quartz cells. Derivative spectra can be evaluated using Fluorescence Data Manager (FLDM) software.
A pH meter (Model pHS-3C, Shanghai Leici Instruments Factory, China) was used to adjust the pH.
Reagents and solutions
Carvedilol and ampicillin sodium (AS) (>99.5%, chemical correspondent product) were used as standards (Chinese Drug and Biological Product Detection Institute). Human serum albumin (HAS) was biochemicals (Huamei Biotechnological Co., Beijing, China). Other reagents were of analytical reagent grade. Double-distilled water was used in all experiments.
Stock standard solutions of carvedilol (1000 µg ml -1 ) and ampicillin sodium (1000 µg ml -1 ) Stock standard solutions of carvedilol and ampicillin sodium were prepared as follows. An accurately weighed 0.1000 g standard sample of carvedilol was dissolved in 5 ml of ethanol, transferred into a 100 ml volumetric flask and diluted to the mark with water and mixed well. In the same way, 0.1000 g ampicillin sodium was dissolved in water directly, transferred into a 100 ml volumetric flask and diluted to the mark with water and mixed well. A HSA solution was freshly prepared with water, and the concentration was 530 µg ml -1 . The carvedilol solution was diluted to 10.0 µg ml -1 and an ampicilin sodium solution was diluted to 100.0 µg ml -1 before being used. All of the solutions were stored at 4˚C.
Michaelis buffer solution (pH 5.3)
A total of 0.1 mol l -1 of HOAc and 0.1 mol l -1 of NaOAc were mixed well according to the volume ratio of 1:4.
Procedure
Procedure I. After a 1.0 ml portion of carvedilol and 1.0 ml ampicillin sodium and 0.20 ml HSA were transferred to a 10.0 ml volumetric flask, respectively, 2.0 ml of a pH 5.3 HOAc/NaOAc buffer solution was added, diluted to the mark with water and mixed well for every volumetric flask. The fluorescence spectra of the excitation and emission of the solutions were recorded. A scan rate of 240 nm min -1 and the excitation/emission windows of 10 nm were used during all of the experiments. Procedure II. After 1.0 ml portions of 10 µg ml -1 carvedilol and 1.0 ml of 100 µg ml -1 AS standard solutions were transferred to a 10.0 ml volumetric flask, 2.0 ml of a pH 5.3 HOAc/NaOAc buffer solution was added, diluted to the mark with water and mixed well. The emission spectra of the solutions were recorded with excitation at 254 nm. The first-derivative fluorescence spectra of the carvedilol and AS were obtained with FLDM software. The number of points (15) was used for deriving the first-derivative spectra. The peak heights of the first-derivative spectra were estimated at 337 nm and 398 nm (peak-to-valley) on the longitudinal coordinate axis (absolute value), respectively. Procedure III. Human blood samples containing carvedilol and AS from volunteers were collected and centrifuged for 3 min. The supernatant was collected and stored at -20˚C. One milliliter of the supernatant was transferred to a 1000 ml volumetric flask, diluted with water and mixed well before being used. This solution was numbered sample solution 1. Sample solution 1 was used as for the determination of carvedilol and AS. Another human blood sample (no contain carvedilol and AS) was treated in the same way, and was called sample solution 2. It was used for determining the recovery of carvedilol and AS. Procedure IV. Urine specimens containing carvedilol and AS from volunteers were collected in 10 ml of 6 mol l -1 hydrochloric acid over a 24 h period and stored at 4˚C. One milliliter of this solution was transferred to a 100 ml volumetric flask, diluted with water and mixed well before being used. This solution was called sample solution 3. It was used as for the determination of carvedilol and AS. Other urine specimens (no contain carvedilol and AS) from volunteers were treated with the same procedure and called sample solution 4. It was used for determining the recovery of carvedilol and AS.
Results and Discussion
First-derivative spectra
According to Procedure I, the excitation and emission spectra of carvedilol, AS and HSA were recorded (Fig. 1) . As can be seen (Fig. 1) , the maximum excitation and emission wavelength of carvedilol were at 254 nm and 357 nm, respectively. The maximum excitation and emission wavelengths of AS were at 260 nm and 426 nm, respectively. Obviously, the emission spectra of carvedilol and ampicillin sodium were partially overlapped. In addition, 254 nm was selected as the coexcitation wavelength for the simultaneous determination of carvedilol and AS. Further, the emission spectrum of HSA spanned from 300 nm to 460 nm with excitation at 254 nm. Obviously, conventional fluorometry cannot be used to simultaneously determine carvedilol and AS in the presence of HSA. However, derivative techniques can be applied to quantitative problems, especially for the analysis of mixtures of compounds whose spectra partially overlap. 25 Figure 2 shows that derivative peaks of carvedilol and AS can be separated entirely, and that carvedilol and AS can be simultaneously determined by first-derivative fluorometry. Obviously, HSA has no effect on the determination of carvedilol and AS. In addition, a1 and a2 were the first-order derivative peaks of carvedilol and AS, respectively. The first derivative peaks of carvedilol and AS were at 337 nm and 398 nm, respectively. The peak heights of the first-derivative spectra were estimated at 337 nm and 398 nm (peak-to-valley) on the longitudinal coordinate axis (absolute value).
Influence of the pH
The effect of the pH on the relative fluorescence intensity of carvedilol and ampicillin sodium was tested. The results are shown in Fig. 3 . The relative fluorescence intensities of both drugs have no change with the pH in the range pH 5 -6. Therefore, a HOAc/NaOAc buffer solution with pH 5.3 was selected to control the pH of the system. In addition, the test showed that the relative fluorescence intensities of both drugs in the presence of HSA were stable for at least in 3 h.
Effect of foreign ions
A systematic study was carried out on the effects of foreign ions on the determination of carvedilol and ampicillin sodium in the presence of HSA. A 500 µg ml -1 level of each interfering species was tested. If interference occurred, the ratio was gradually decreased untill the interference ceased.
The tolerance level was defined as an error not exceeding ±5% in the determination of the analyte. The results are summarized in Table 1 .
Calibration graph of carvedilol and ampicillin sodium
Under the selected conditions, a linear relationship was obtained between the height of the first derivative curve (peakto-valley) and the concentration of carvedilol in the range of 0.002 µg ml -1 to 0.08 µg ml -1 . The linear-regression equation of the calibration graph was C = 0.0001H -0.0063, with a correlation coefficient of having a linear regression of 0.9990. In the same way, the linear range for ampicillin sodium was from 30 µg ml -1 to 450 µg ml -1 , and the linear-regression equation of the calibration graph was C = 1.530H -43.84, with a correlation coefficient of the linear regression of 0.9986.
Recoveries of carvedilol and ampicillin sodium Recoveries of carvedilol and ampicillin sodium in a human serum sample.
According to Procedure II, different concentrations of carvedilol and AS were added to sample solution 2, prepared according to Procedure III; the recoveries of carvedilol and AS were measured. The results are shown in Tables 2 and 3 . The recovery of carvedilol was from 103.0 to 115.5%, and the recovery of ampicillin sodium was from 102.0 to 105.3% in a human serum sample.
Recoveries of carvedilol and ampicillin sodium in a urine sample.
According to Procedure II, after different concentrations of carvedilol and AS were added to sample solution 4, prepared according to Procedure IV, the recoveries of carvedilol and AS were measured. The results are shown in Tables 4 and 5 . The recovery of carvedilol was from 96.7 to 103.0%, and that of ampicillin sodium was from 98.6 to 101.2% in a urine sample.
Analysis of sample
According to Procedure II, carvedilol and AS were measured in a human serum sample and a urine sample. The results are shown in Table 6 . It was noted that the human serum and urine 539 ANALYTICAL SCIENCES MAY 2005, VOL. 21 ; concentration of ampicillin sodium, 10 µg ml -1 . Recovery, % Recovery, % samples were diluted to appropriate concentrations in order that the carvedilol and AS locate in the range of the calibration graph before carvedilol and AS in the samples were determined. It should be noticed that amino acid and vitamins also emit fluorescences, which will interfere with the determination of both drugs. It is difficult to determine the concentrations of both drugs in real samples of the human body. However, these interferences can be eliminated by diluting the sample and using the derivative method in our test.
Reproducibility and detection limit
According to Procedure II, a portion of the sample solution of carvedilol and ampicillin sodium in the presence of HSA was measured 10 times (n = 10). The mean value of carvedilol was 0.014 µg ml -1 with an RSD of 3.22%, and the mean value of ampicillin sodium was 107.8 µg ml -1 with an RSD of 4.29%. A reagent blank, treated in the same way, was measured 10 times, based on the blank plus three-times the standard deviation of the blank. 26 The detection limits of carvedilol and ampicillin sodium were 1 ng ml -1 and 23 µg ml -1 , respectively.
In the present work, it was clearly demonstrated that carvedilol and ampicillin sodium in the presence of HSA can be simultaneously determined by derivative fluorometry. This method is simple and can be used for the determination of carvedilol and AS in human serum and urine.
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